PC190723

CAS No. 951120-33-5

PC190723( —— )

Catalog No. M35536 CAS No. 951120-33-5

PC190723 is a bacterial cytosolic protein FtsZ inhibitor (IC50: 55 ng/ml) with antimicrobial activity that inhibits Staphylococcus spp.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 347 In Stock
5MG 468 In Stock
10MG 753 In Stock
25MG 1086 In Stock
50MG 1500 In Stock
100MG 1971 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    PC190723
  • Note
    Research use only, not for human use.
  • Brief Description
    PC190723 is a bacterial cytosolic protein FtsZ inhibitor (IC50: 55 ng/ml) with antimicrobial activity that inhibits Staphylococcus spp.
  • Description
    PC190723 (Compound 2) is an inhibitor of the bacterial cell division protein FtsZ with an IC50 of 55 ng/ml. FtsZ-IN-3 exhibits anti-staphylococcal activity with MIC values of 1 μg/ml for MSSA and MRSA.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Microbiology/Virology
  • Target
    Antibiotic
  • Recptor
    Antibiotic | Antibacterial
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    951120-33-5
  • Formula Weight
    355.75
  • Molecular Formula
    C14H8ClF2N3O2S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 200 mg/mL (562.19 mM; Ultrasonic )
  • SMILES
    O=C(N)C=1C(F)=CC=C(OCC2=NC=3C=C(Cl)C=NC3S2)C1F
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Buroni S, et al. The cell division protein FtsZ as a cellular target to hit cystic fibrosis pathogens. Eur J Med Chem. 2020 Mar 15;190:112132. ?
molnova catalog
related products
  • Nifursemizone

    Nifursemizone is an agent with antiprotozoal.

  • N6-Bz-5-O-DMTr-3-deo...

    N6-Bz-5'-O-DMTr-3'-deoxyadenosine-2'-O-CED-phosphoramidite, an adenine nucleoside analog, has potential vasodilator and anticancer activities relevant to cancer research.

  • anti-TB agent 1

    Anti-TB agent 1 is a potent and orally active anti-tuberculosis compound (MICs: < 2 nM against the Mtb strains H37Rv, rRMP, and rINH).